{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T07:09:20Z","timestamp":1719558560664},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s11864-006-0042-5","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T18:21:58Z","timestamp":1183573318000},"page":"326-333","source":"Crossref","is-referenced-by-count":11,"title":["Surgical approach to the patient with familial hyperparathyroidism"],"prefix":"10.1007","volume":"7","author":[{"given":"Lindi H.","family":"VanderWalde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip I.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"42_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/archsurg.137.6.641","volume":"137","author":"MA Kouvaraki","year":"2002","unstructured":"Kouvaraki MA, Lee JE, Shapiro SE, et al.: Genotypephenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 2002, 137:641\u2013647.","journal-title":"Arch Surg"},{"key":"42_CR2","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/bjs.4355","volume":"90","author":"P Langer","year":"2003","unstructured":"Langer P, Wild A, Hall A, et al.: Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours. Br J Surg 2003, 90:1599\u20131603.","journal-title":"Br J Surg"},{"key":"42_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00268-004-7560-8","volume":"28","author":"GM Doherty","year":"2004","unstructured":"Doherty GM, Lairmore TC, DeBenedetti MK: Multiple endocrine neoplasia type 1 parathyroid adenoma development over time. World J Surg 2004, 28:1139\u20131142.","journal-title":"World J Surg"},{"key":"42_CR4","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, et al.: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86:5658\u20135671. International consensus statement on the treatment of MEN type 1 and 2.","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR5","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00268-001-0046-z","volume":"25","author":"P Goudet","year":"2001","unstructured":"Goudet P, Cougard P, Verges B, et al.: Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe d\u2019Etude des N\u00e9oplasies Endocriniennes Multiples Study Group. World J Surg 2001, 25:886\u2013890. Largest cohort published on MEN-1 patients with hyperparathyroidism.","journal-title":"World J Surg"},{"key":"42_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1067\/msy.2002.128607","volume":"132","author":"LC Arnalsteen","year":"2002","unstructured":"Arnalsteen LC, Alesina PF, Quiereux JL, et al.: Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 2002, 132:1119\u20131125.","journal-title":"Surgery"},{"key":"42_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/110241501750099294","volume":"167","author":"C Dotzenrath","year":"2001","unstructured":"Dotzenrath C, Cupisti K, Goretzki PE, et al.: Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia type I and IIa: is a more or less extended operation essential. Eur J Surg 2001, 167:173\u2013178.","journal-title":"Eur J Surg"},{"key":"42_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1245\/ASO.2006.12.009","volume":"13","author":"CH Lee","year":"2006","unstructured":"Lee CH, Tseng LM, Chen JY, et al.: Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol 2006, 13:103\u2013109.","journal-title":"Ann Surg Oncol"},{"key":"42_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","volume":"134","author":"DM Elaraj","year":"2003","unstructured":"Elaraj DM, Skarulis MC, Libutti SK, et al.: Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 2003, 134:858\u2013865.","journal-title":"Surgery"},{"key":"42_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","volume":"140","author":"LA Lambert","year":"2005","unstructured":"Lambert LA, Shapiro SE, Lee JE, et al.: Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 2005, 140:374\u2013382.","journal-title":"Arch Surg"},{"key":"42_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1067\/msy.2001.118379","volume":"130","author":"MH Kivlen","year":"2001","unstructured":"Kivlen MH, Bartlett DL, Libutti SK, et al.: Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 2001, 130:991\u2013998.","journal-title":"Surgery"},{"key":"42_CR12","first-page":"493","volume-title":"Textbook of Endocrine Surgery","author":"M Sierra","year":"2005","unstructured":"Sierra M, Gibelin H, Kraimps JL: Familial hyperparathyroidism in multiple endocrine neoplasia syndromes. In Textbook of Endocrine Surgery, edn 2. Edited by Clark OH, Duh QY, Kebebew E. Philadelphia: Elsevier; 2005:493\u2013501.","edition":"edn 2"},{"key":"42_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.2002-021314","volume":"88","author":"F Gibril","year":"2003","unstructured":"Gibril F, Chen YJ, Schrump DS, et al.: Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Enocrinol Metab 2003, 88:1066\u20131081. A prospective analysis of MEN-1 patients and their risk of developing thymic carcinoid.","journal-title":"J Clin Enocrinol Metab"},{"key":"42_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","volume":"228","author":"BT Teh","year":"1998","unstructured":"Teh BT, Zedenius J, Kytola S, et al.: Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 1998, 228:99\u2013105.","journal-title":"Ann Surg"},{"key":"42_CR15","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1210\/jc.2004-1155","volume":"90","author":"P Ferolla","year":"2005","unstructured":"Ferolla P, Falchetti A, Filosso P, et al.: Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 2005, 90:2603\u20132609.","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2265.2001.01348.x","volume":"55","author":"JR Burgess","year":"2001","unstructured":"Burgess JR, Giles N, Shepherd JJ: Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. Clin Endocrinol 2001, 55:689\u2013693.","journal-title":"Clin Endocrinol"},{"key":"42_CR17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s002689900123","volume":"20","author":"JL Kraimps","year":"1996","unstructured":"Kraimps JL, Denizot A, Carnaille B, et al.: Primary hyperparathyroidism in multiple endocrine neoplasia type Iia: retrospective French multicentric study. World J Surg 1996, 20:808\u2013813.","journal-title":"World J Surg"},{"key":"42_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","volume":"238","author":"F Raue","year":"1995","unstructured":"Raue F, Kraimps JL, Dralle H, et al.: Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Int Med 1995, 238:369\u2013371. Largest cohort on MEN-2A and hyperparathyroidism.","journal-title":"J Int Med"},{"key":"42_CR19","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0039-6060(96)80042-0","volume":"120","author":"KK Herfarth","year":"1996","unstructured":"Herfarth KK, Bartsch F, Doherty GM, et al.: Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery 1996, 120:966\u2013974.","journal-title":"Surgery"},{"key":"42_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s002689900124","volume":"20","author":"RA Decker","year":"1996","unstructured":"Decker RA, Geiger JD, Cox CE, et al.: Prophylactic surgery for multiple endocrine neoplasia type Iia after genetic diagnosis: is parathyroid transplantation indicated. World J Surg 1996, 20:814\u2013821.","journal-title":"World J Surg"},{"key":"42_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/jmg.2003.016725","volume":"41","author":"J Warner","year":"2004","unstructured":"Warner J, Epstein M, Sweet A, et al.: Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 2004, 41:155\u2013160.","journal-title":"J Med Genet"},{"key":"42_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1046\/j.1365-2265.2003.01765.x","volume":"58","author":"AAJ Pannett","year":"2003","unstructured":"Pannett AAJ, Kennedy AM, Turner JJO, et al.: Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol 2003, 58:639\u2013646.","journal-title":"Clin Endocrinol"},{"key":"42_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1210\/jc.85.4.1449","volume":"85","author":"CJ Haven","year":"2000","unstructured":"Haven CJ, Wong FK, van Dam EW, et al.: A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 2000, 85:1449\u20131454.","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/qjmed\/94.4.213","volume":"94","author":"BM Cavaco","year":"2001","unstructured":"Cavaco BM, Barros L, Pannett AA, et al.: The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. Q J Med 2001, 94:213\u2013222.","journal-title":"Q J Med"},{"key":"42_CR25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/B978-0-7216-0139-7.50059-4","volume-title":"Textbook of Endocrine Surgery","author":"SM Huang","year":"2005","unstructured":"Huang SM: Familial hyperparathyroidism. In Textbook of Endocrine Surgery, edn 2. Edited by Clark OH, Duh QY, Kebebew E. Philadelphia: Elsevier; 2005:493\u2013501.","edition":"edn 2"},{"key":"42_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1067\/msy.2002.120674","volume":"131","author":"E Szabo","year":"2002","unstructured":"Szabo E, Hellman P, Lundgren E, et al.: Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuria hypercalcemia. Surgery 2002, 131:257\u2013263.","journal-title":"Surgery"},{"key":"42_CR27","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1210\/jc.2003-030908","volume":"89","author":"AA Khan","year":"2004","unstructured":"Khan AA, Bilezikian JP, Kung AW, et al.: Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trail. J Clin Endocrinol Metab 2004, 89:3319\u20133325.","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/jc.2002-020890","volume":"88","author":"CC Chow","year":"2003","unstructured":"Chow CC, Chan WB, Li JK, et al.: Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88:581\u2013587.","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR29","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1210\/jc.2001-010385","volume":"87","author":"CR Parker","year":"2002","unstructured":"Parker CR, Blackwell PJ, Fairbairn KJ, Hosking DJ: Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. J Clin Endocrinol Metab 2002, 87:4482\u20134489.","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000048935","volume":"48","author":"T Horiuchi","year":"2002","unstructured":"Horiuchi T, Onouchi T, Inoue J, et al.: A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy. Gerontology 2002, 48:103\u2013108.","journal-title":"Gerontology"},{"key":"42_CR31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1067\/msy.2002.128695","volume":"132","author":"DM Carniero","year":"2002","unstructured":"Carniero DM, Irvin GL, Inabnet WB: Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery 2002, 132:1050\u20131055.","journal-title":"Surgery"},{"key":"42_CR32","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s002689910091","volume":"24","author":"F Tonelli","year":"2000","unstructured":"Tonelli F, Spini S, Tommasi M, et al.: Intraoperative parathormone measurements in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. World J Surg 2000, 24:556\u2013563.","journal-title":"World J Surg"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-006-0042-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-006-0042-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-006-0042-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-006-0042-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T14:18:22Z","timestamp":1652624302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-006-0042-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s11864-006-0042-5","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}